by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

Respilon Production S.R.O. Warning Letter Details

Warning Letter

Respilon Production S.R.O.

Prikop 843/4 Brno 602 00 Jihomoravsky Czechia

Issue DateApril 20, 2026

FEI Number3018892481

Violations5

CountryCzechia

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

CGMP/OTC/Finished Pharmaceuticals/Adulterated

Respilon Production S.R.O. FDA Warning Letter, April 20, 2026